Corneal Collagen Crosslinking With Riboflavin for Keratoconus Treatment: A Brazilian Study
|ClinicalTrials.gov Identifier: NCT00642044|
Recruitment Status : Unknown
Verified March 2008 by Universidade Federal do Rio de Janeiro.
Recruitment status was: Recruiting
First Posted : March 24, 2008
Last Update Posted : April 23, 2008
|Condition or disease||Intervention/treatment||Phase|
|Keratoconus||Procedure: Corneal Collagen Crosslinking||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||100 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Corneal Collagen Crosslinking With Riboflavin for Keratoconus Treatment: A Brazilian Study|
|Study Start Date :||February 2007|
|Estimated Primary Completion Date :||December 2008|
|Estimated Study Completion Date :||December 2009|
The eye with the worst visual acuity receives the treatment. (the other eye serve as control).
Procedure: Corneal Collagen Crosslinking
UV light and Riboflavin eyedrops every 5 minutes for 30 minutes.
No Intervention: B
The eye with the best visual acuity do not receive the treatment.
- Keratometry [ Time Frame: 3 months ]
- BSCVA (Best spectacle corrected visual acuity) [ Time Frame: 3 months ]
- Endothelial cell count [ Time Frame: 3 months ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00642044
|Contact: Ricardo Lamy, MDemail@example.com|
|Clementino Fraga Filho University Hospital||Recruiting|
|Rio de Janeiro, RJ, Brazil, 21941-913|
|Contact: Ricardo Lamy firstname.lastname@example.org|
|Principal Investigator: Ricardo Lamy, MD|
|Principal Investigator:||Ricardo Lamy, MD||UFRJ|